BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 24733273)

  • 21. The -765G>C polymorphism in the cyclooxygenase-2 gene and digestive system cancer: a meta-analysis.
    Zhao F; Cao Y; Zhu H; Huang M; Yi C; Huang Y
    Asian Pac J Cancer Prev; 2014; 15(19):8301-10. PubMed ID: 25339021
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potentially functional COX-2-1195G>A polymorphism increases the risk of digestive system cancers: a meta-analysis.
    Dong J; Dai J; Zhang M; Hu Z; Shen H
    J Gastroenterol Hepatol; 2010 Jun; 25(6):1042-50. PubMed ID: 20594217
    [TBL] [Abstract][Full Text] [Related]  

  • 23. XRCC1 polymorphisms and risk of colorectal cancer: a meta-analysis.
    Wang B; Wang D; Huang G; Zhang C; Xu DH; Zhou W
    Int J Colorectal Dis; 2010 Mar; 25(3):313-21. PubMed ID: 20033188
    [TBL] [Abstract][Full Text] [Related]  

  • 24. GSTP1 Ile105Val polymorphism and colorectal cancer risk: an updated analysis.
    Tan Z; Feng M; Luo Y; Sun C; Fan Z; Tan Y; Fu B; Lang J
    Gene; 2013 Sep; 527(1):275-82. PubMed ID: 23811488
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Cox-2 -1195 G > A polymorphism and cancer risk: a meta-analysis of 25 case-control studies.
    Tang Z; Nie ZL; Pan Y; Zhang L; Gao L; Zhang Q; Qu L; He B; Song G; Zhang Y; Shukui Wang
    Mutagenesis; 2011 Nov; 26(6):729-34. PubMed ID: 21734230
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The association between CCND1 G870A polymorphism and colorectal cancer risk: A meta-analysis.
    Xie M; Zhao F; Zou X; Jin S; Xiong S
    Medicine (Baltimore); 2017 Oct; 96(42):e8269. PubMed ID: 29049220
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association between rs738409 polymorphism in patatin-like phospholipase domain-containing protein 3 (PNPLA3) gene and hepatocellular carcinoma susceptibility: Evidence from case-control studies.
    Li JF; Zheng EQ; Xie M
    Gene; 2019 Feb; 685():143-148. PubMed ID: 30403964
    [TBL] [Abstract][Full Text] [Related]  

  • 28. COX-2 rs5275 and rs689466 polymorphism and risk of lung cancer: A PRISMA-compliant meta-analysis.
    Li J; Lu X; Zou X; Jiang Y; Yao J; Liu H; Ni B; Ma H
    Medicine (Baltimore); 2018 Aug; 97(35):e11859. PubMed ID: 30170377
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The -765C allele of the cyclooxygenase-2 gene as a potential risk factor of colorectal cancer: a meta-analysis.
    Cao H; Xu Z; Long H; Li XQ; Li SL
    Tohoku J Exp Med; 2010 Sep; 222(1):15-21. PubMed ID: 20808059
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lack of association between XPD Lys751Gln and Asp312Asn polymorphisms and colorectal cancer risk: a meta-analysis of case-control studies.
    Zhang Y; Ding D; Wang X; Zhu Z; Huang M; He X
    Int J Colorectal Dis; 2011 Oct; 26(10):1257-64. PubMed ID: 21541661
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Associations of tumor necrosis factor-α polymorphisms with the risk of colorectal cancer: a meta-analysis.
    Huang X; Qin S; Liu Y; Tao L; Jiang H
    Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30509966
    [No Abstract]   [Full Text] [Related]  

  • 32. Association between ATM rs1801516 polymorphism and cancer susceptibility: a meta-analysis involving 12,879 cases and 18,054 controls.
    Gu Y; Shi J; Qiu S; Qiao Y; Zhang X; Cheng Y; Liu Y
    BMC Cancer; 2018 Nov; 18(1):1060. PubMed ID: 30384829
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of NQO1 rs1800566 polymorphism and the risk of colorectal cancer: a meta-analysis.
    Ding R; Lin S; Chen D
    Int J Colorectal Dis; 2012 Jul; 27(7):885-92. PubMed ID: 22215148
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The association between three cyclooxygenase-2 polymorphisms and hepatocellular carcinoma risk: a meta-analysis.
    Chen Z; Zhu J; Huang C; Lian F; Wu G; Zhao Y
    PLoS One; 2015; 10(3):e0118251. PubMed ID: 25730260
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Associations of functional polymorphisms in cyclooxygenase-2 and platelet 12-lipoxygenase with risk of occurrence and advanced disease status of colorectal cancer.
    Tan W; Wu J; Zhang X; Guo Y; Liu J; Sun T; Zhang B; Zhao D; Yang M; Yu D; Lin D
    Carcinogenesis; 2007 Jun; 28(6):1197-201. PubMed ID: 17151091
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of IL-6 -174 G>C Polymorphism with Susceptibility to Colorectal Cancer and Gastric Cancer: a Systematic Review and Meta-Analysis.
    Jafari-Nedooshan J; Dastgheib SA; Kargar S; Zare M; Raee-Ezzabadi A; Heiranizadeh N; Sadeghizadeh-Yazdi J; Neamatzadeh H
    Acta Medica (Hradec Kralove); 2019; 62(4):137-146. PubMed ID: 32036845
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cyclooxygenase-2 gene and lung carcinoma risk.
    Coskunpinar E; Eraltan IY; Turna A; Agachan B
    Med Oncol; 2011 Dec; 28(4):1436-40. PubMed ID: 20645029
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic polymorphisms of TP53 (rs1042522) and MDM2 (rs2279744) and colorectal cancer risk: An updated meta-analysis based on 59 case-control studies.
    Elshazli RM; Toraih EA; Elgaml A; Kandil E; Fawzy MS
    Gene; 2020 Apr; 734():144391. PubMed ID: 32001373
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association between CYP1A1 2454A > G polymorphism and colorectal cancer risk: A meta-analysis.
    Xu L; Wei H
    J Cancer Res Ther; 2015; 11(4):760-4. PubMed ID: 26881514
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association between APE1 ASP148GLU and colorectal cancer risk: A meta-analysis.
    Lin C; Jin Y; Cheng S; Wang W
    Clin Invest Med; 2020 Dec; 43(4):E24-34. PubMed ID: 33370522
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.